Antimalarial drug resistance and combination chemotherapy

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 354, Issue 1384, 1999, Pages 739-749

  White, Nicholas ^a,b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Centre for Tropical Diseases Vietnam   (Viet Nam)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Antimalarials; Artemisinin; Combinations; Resistance

Indexed keywords

ANIMALIA; PLASMODIUM FALCIPARUM;

EID: 0033614329     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1999.0426     Document Type: Article

References (61)

1. Baird, J. K., Bassi, H. P., Bangs, M. J., Subianto, B., Patchen, L. C. & Hoffman, S. L. 1991 Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 44, 547-552.
2. Bloland, P. B., Kazembe, P. N., Oloo, A. J., Himonga, B., Barat, L. M. & Ruebush, T. K. 1998 Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop. Med. Int. Health 3, 543-552.
3. Bonhoeffer, S., Lipsitch, M. & Levin, B. R. 1997 Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl Acad. Sci. USA 94, 12106-12111.
4. Brooks, D. R., Wang, P., Read, M., Watkins, W. M., Sims, P. F. & Hyde J. E. 1994 Sequence variation of the hydroxymethyl- dihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulphadoxine. Eur. J. Biochem. 224, 397-405.
5. Butcher, G. A. 1997 Antimalarial drugs and the mosquito transmission of Plasmodium. Int. J. Parasitol. 27, 975-987.
6. Canfield, C. J., Pudney, M. & Gutteridge, W. E. 1995 Interaction of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80, 373-381.
7. Carter, P., & Miller, L. H. 1979 Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull. WHO 57 (Suppl. 1), 37-52.
8. Chawira, A. N., Warhurst, D. C., Robinson, B. L. & Peters, W. 1987 The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans. R. Soc. Trop. Med. Hyg. 81, 554-558.
9. Cowman, A. F., Galatis, D. & Thompson, J. K. 1994 Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl Acad. Sci. USA 91, 1143-1147.
10. Curtis, C. F. & Otoo, L. N. 1986 A simple model of the build-up of resistance to mixtures of antimalarial drugs. Trans. R. Soc. Trop. Med. Hyg. 80, 889-892.
11. Curtis, J., Duraisingh, M. T. & Warhurst, D. C. 1998 In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulphadoxine but not chlorproguanil-dapsone treatment. J. Infect. Dis. 177, 1429-1433.
12. Dorn, A., Stoffel, R., Matile, H., Bubendorf, A. & Ridley, R. G. 1995 Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature 374, 269-271.
13. Dye, C. 1991 Population genetics of nonclonal, nonrandomly mating malaria parasites. Parasitol. Today 9, 236-240.
14. Dye, C. & Williams, B. G. 1997 Multigenic drug resistance among inbred malaria parasites. Proc. R. Soc. Lond. B 264, 61-67.
15. Foote, S. J. & Cowman, A. F. 1994 The mode of action and the mechanism of resistance to antimalarial drugs. Acta Tropica 56, 157-171.
16. Foote, S. J., Galatis, D. & Cowman, A. F. 1990 Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc. Natl Acad. Sci. USA 87, 3014-3017.
17. Gay, F., Ciceron L., Litaudon, M., Bustos, M. D., Astagneau, P., Diquet B., Danis M. & Gentilini, M. 1994 In vitro resistance of Plasmodium falciparum to qinghaosu derivatives in west Africa. Lancet 343, 850-851.
18. Hassan Alin, M., Ashton, M., Kihamia, C. M., Mtey, G. J. B. & Bjorkman, A. 1996 Multiple dose pharmacokinetics of artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans. R. Soc. Trop. Med. Hyg. 90, 61-65.
19. Hastings, I. M. 1997 A model for the evolution and spread of drug resistant malaria. Parasitology 115, 133-142.
20. Hill, W. G., Babiker, H. A., Ranford-Cartwright, L. C. & Walliker, D. 1995 Estimation of inbreeding coefficients from genotypic data on multiple alleles, and application to clonality in malaria parasites. Genetical Res. 65, 53-61.
21. Hogh, B. (and 10 others) 1998 The differing impact of chloroquine and pyrimethamine/sulphadoxine upon the infectivity of malaria species to the mosquito vector. Am. J. Trop. Med. Hyg. 58, 176-182.
22. Jeffery, G. M. & Eyles, D. E. 1955 Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am. J. Trop. Med. Hyg. 4, 781-789.
23. Jeffery, G. M., Young, M. D. & Eyles, D. E. 1956 The treatment of Plasmodium falciparum infection with chloroquine, with a note on infectivity to mosquitoes of primaquine and pyrimethamine-treated cases. Am. J. Hyg. 64, 1-11.
24. Kamchonwongpaisan, S. & Meshnick, S. R. 1996 The mode of action of the antimalarial artemisinin and its derivatives. General Pharmacol. 27, 587-592.
25. Koella, J. C. 1998 Costs and benefits of resistance against antimalarial drugs. Parasitol. Today 14, 360-364.
26. Lipsitch, M. & Levin, B. R. 1997 The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 41, 363-373.
27. Looareesuwan, S., Viravan C., Webster, H. K., Kyle, D. E., Hutchinson, D. B. & Canfield, C. J. 1996 Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54, 62-66.
28. Mackinnon, M. J. & Hastings, I. M. 1998 The evolution of multiple drug resistance in malaria parasites. Trans. R. Soc. Trop. Med. Hyg. 92, 188-195.
29. Marsh, K. 1998 Malaria disaster in Africa. Lancet 352, 924-925.
30. Meshnick, S. R., Taylor, T. E. & Kamchonwongpaisan, S. 1996 Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60, 301-315.
31. Nosten, F., ter Kuile, F., Chongsuphajaisiddhi, T., Luxemburger, C., Webster, H. K., Edstein, M., Phaipun, L., Thew, K. L. & White, N. J. 1991 Mefloquine-resistant falciparum malaria on the Thai Burmese border. Lancet 337, 1140-1143.
32. Olliaro, P., Nevill, C., Lebras, J., Ringwald, P., Mussano, P., Garner, P. & Brasseur, P. 1996 Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348, 1196-1201.
33. Paul, R. E. L., Packer, M. J., Walmsley, M., Lagog, M., Ranford-Cartwright, L. C., Paru, R. & Day, K. P. 1995 Mating patterns in malaria parasite populations of Papua New Guinea. Science 269, 1709-1711.
34. Peel, S. A., Merritt, S. C., Handy, J. & Baric, R. S. 1993 Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. Am. Soc. Trop. Med. Hyg. 48, 385-397.
35. Peters, W. 1990 The prevention of antimalarial drug resistance. Pharmacol. Ther. 47, 499-508.
36. Peters, W. & Robinson, B. L. 1984 The chemotherapy of rodent malaria XXXV: further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulphadoxine in mice infected with P. berghei and 'P. berghei NS'. Ann. Trop. Med. Parasitol. 78, 459-466.
37. Peterson, D. S., Walliker, D. & Wellems, T. E. 1988 Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl Acad. Sci. USA 85, 9114-9118.
38. Price, R. N., Nosten, F., Luxemburger, C., Van Vugt, M., Phaipun, L., Chongsuphajaisiddhi, T. & White, N. J. 1997 Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 91, 574-577.
39. Rathod, P. K., McErlean, T. & Lee, P. 1997 Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 94, 9389-9393.
40. Reeder, J. C., Rieckmann, K., Genton, B., Lorry, K., Wines, B. & Cowman, A. F. 1996 Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am. Soc. Trop. Med. Hyg. 55, 209-213.
41. Rieckmann, K. H., Davis, D. R. & Hutton, D. C. 1989 Plasmodium vivax resistance to chloroquine. Lancet 2, 1183-1184.
42. Rosario, V. E., Hall, R., Walliker, D. & Beale, G. H. 1978 Persistence of drug-resistant malaria parasites. Lancet 1, 185-187.
43. Sinden, R. E., Butcher, G. A., Billker, O. & Fleck, S. L. 1996 Regulation of infectivity of Plasmodium to the mosquito vector. Adv. Parasitol. 38, 53-117.
44. Slater, A. F. 1993 Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. Pharmacol. Ther. 57, 203-235.
45. Snow, R. W., Peshu, N., Forster, D., Mwenesi, H. & Marsh, K. 1992 The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. Trans. R. Soc. Trop. Med. Hyg. 86, 237-239.
46. Su, X., Kirkman, L. A., Fujioka, H. & Wellems, T. E. 1998 Complex polymorphisms in an 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91, 593-603.
47. ter Kuile, F., White, N. J., Holloway, P., Pasvol, G. & Krishna, S. 1993 Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp. Parasitol. 76, 86-95.
48. Trape, J. F., Pison, G., Preziosi, M. P., Enel, C., Desgrees du Lai, A., Delaunay, V., Samb, B., Lagarde, E., Molez, J. F. & Simondon, F. 1998 Impact of chloroquine resistance on malaria mortality. C. R. Acad. Sci. Paris, serie 3 321, 689-697.
49. Wang, P., Read, M., Sims, P. F. G. & Hyde, J. E. 1997 Sulphadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol. Microbiol. 23, 979-986.
50. Ward, S. A., Bray, P. G., Mungthin, M. & Hawley, S. R. 1995 Current views on the mechanisms of resistance to quinoline-containing drugs in Plasmodium falciparum. Ann. Trop. Med. Parasitol. 89, 121-124.
51. Watkins, W. M. & Mosobo, M. 1993 Treatment of Plasmodium falciparum malaria with pyrimethamine-sulphadoxine: selective pressure for resistance is a function of long elimination half-life. Trans. R. Soc. Trop. Med. Hyg. 87, 75-78.
52. Watkins, W. M., Brandling-Bennett, A. D., Nevill, C. G., Carter, J. Y., Boriga, D. A., Howells, R. E. & Koech, D. K. 1988 Chlorproguanil/dapsone for the treatment of non-severe Plasmodium falciparum infection in Kenya. Trans. R. Soc. Trop. Med. Hyg. 82, 398-403.
53. Watkins, W. M., Mberu, E. K., Winstanley, P. A. & Plowe, C. V. 1997 The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analysis. Parasitol. Today 13, 459-464.
54. Wernsdorfer, W. H., Landgraf, B., Wiedermann, G. & Kollaritsch, H. 1994 Inverse correlation of sensitivity in vitro of Plasmodium falciparum to chloroquine and mefloquine in Ghana. Trans. R. Soc. Trop. Med. Hyg. 88, 443-444.
55. White, N. J. & Krishna, S. 1989 Treatment of malaria: some considerations and limitations of the current methods of assessment. Trans. R. Soc. Trop. Med. Hyg. 83, 767-777.
56. White, N. J. 1992a Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30, 571-585.
57. White, N. J. 1992b Antimalarial pharmacokinetics and treatment regimens. Br. J. Clin. Pharmacol. 34, 1-10.
58. White, N. J. 1997 Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41, 1413-1422.
59. White, N. J. 1998 Preventing antimalarial drug resistance through combinations. Drug Resist. Updates 1, 3-9.
60. Wilson, C. M., Volkman, S. K., Thaithong, S., Martin, R. K., Kyle, D. E., Milhous, W. K. & Wirth, D. F. 1993 Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57, 151-160.
61. Zucker, J. R., Lackritz, E. M., Ruebush, T. K., Hightower, A. W., Adungosi, J. E. Were, J. B. O., Metchock, B., Patrick, E. & Campbell, C. C. 1996 Childhood mortality during and after hospitalization in Western Kenya: effect of malaria treatment regimens. Am. J. Trop. Med. Hyg. 55, 655-660.